longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Yili Chuanning Bio

301301

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI
  • Weekly Recap | Zai Lab +0.58%, most brokers rate it buy

    Weekly Review·Sep 5 at 08:27 AM
    - Zai Lab cumulative weekly stock price rose 0.58 % to close at 26.23 dollars, outperforming the S & P 500. - A total of 12 institutions provided ratings with a consensus target price of 33.14 dollars, reflecting a significant valuation divergence ranging from 24.25 dollars to 50.00 dollars. - The company released no new announcements during the week, while market focus centered on VYVGART Hytrulo product data and subsequent capital revaluation trends.
    ZLAB-0.12%
  • A-shares closing: The ChiNext index fell nearly 2% on reduced volume, while the synthetic biology concept surged against the trend

    Wallstreetcn·May 15, 2025 at 07:02 AM
    301108+0.17%603630-4.05%